Perrigo rose strongly on news it had sold its generic division but Ormat continues its plunge.
Ormat and Teva both fell as Liverperson bucked the market with strong gains.
The main indices fell today, leaving the Tel Aviv 35 Index down 2.1% for the week, but all five leading stocks rose.
Teva and Ormat led the gains today but NICE Systems continued to slide.
NICE, Teva and Ormat fell steeply while Energean bucked the market.
NICE, Teva and Ormat led the declines today as Melisron bucked the market.